Evidence map›Paper›PMID 40890475›Full record

ArticleScientific reports2025

3D printed antibacterial and anti-inflammatory scaffold containing vanillin-loaded Soluplus nanomicelles for healing of infected wounds.

Zainab Farooq Shafeeq, Fitua Al-Saedi, Eslah Shakir Rajab, Mastafa H Al-Musawi, Farah E Ismaeel, Shima Najafi, Maryam Vesal, Salar Nasr Esfahani, Fariborz Sharifianjazi, Ketevan Tavamaishvili and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Zainab Farooq ShafeeqDepartment of Clinical Laboratory Sciences, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.
Fitua Al-SaediDepartment of Clinical Laboratory Sciences, College of Pharmacy, Mustansiriyah University, Baghdad, Iraq.
Eslah Shakir RajabDepartment of Microbiology, College of Science, Al Karkh University for Science, Baghdad, Iraq.
Mastafa H Al-MusawiDepartment of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq. mustafa.h.j@uomustansiriyah.edu.iq.
Farah E IsmaeelHuman Anatomy Department, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
Shima NajafiDepartment of Textile Engineering, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Maryam VesalDepartment of Biophysics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, 14115-154, Iran.
Salar Nasr EsfahaniDepartment of Pathology, School of Medicine, Arak University of Medical Sciences, Arak, Iran.
Fariborz SharifianjaziCenter for Advanced Materials and Structures, School of Science and Technology, The University of Georgia, 0171, Tbilisi, Georgia.
Ketevan TavamaishviliSchool of Medicine, Georgian American University, 10 Merab Aleksidze Str., 0160, Tbilisi, Georgia.
Marjan MirhajDepartment of Materials Engineering, Isfahan University of Technology, Isfahan, 84156-83111, Iran. marjan.mirhaj@yahoo.com.
Mohamadreza TavakoliDepartment of Materials Engineering, Isfahan University of Technology, Isfahan, 84156-83111, Iran. mtavakoli6323@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treating infected wounds is a major clinical challenge, and concerns about bacterial resistance have driven the shift toward natural antimicrobials over antibiotics. Herein, a 3D printed scaffold wound dressing consisting of alginate (Alg) and fucoidan (F) was prepared, and Soluplus (Sol) nanomicelles (NMs) were used to load vanillin (Vn) as a lipophilic antibacterial agent into the 3D printed scaffold. Characterization analyses revealed that the fabricated scaffold exhibited a peak swelling capacity of 294.3 ± 24.1% and underwent a weight loss of 38.0 ± 2.25% following a seven-day immersion in PBS. The Vn release from the Alg-F-VnNMs scaffold reached 80.6 ± 5.3% after seven days of immersion in PBS. The controlled release of Vn from the scaffold resulted in inhibition zones of 21.4 ± 1.15 mm against S. aureus and 23.2 ± 0.9 mm against E. coli within 24 h, while further analysis displayed a potent bactericidal effect, eradicating more than 80% of the bacterial population. In vivo studies on a full-thickness rat wound model showed that the Alg-F-VnNMs scaffold reduced inflammation, enhanced collagen deposition, and accelerated regeneration, leading to complete wound healing in 14 days, confirming its efficacy in wound management and skin repair.

Indexed as

Anti-Bacterial AgentsAnti-Inflammatory AgentsBenzaldehydesPolyethylene GlycolsPolyvinylsPrinting, Three-DimensionalWound HealingWound InfectionAnimalsBandagesEscherichia coliMaleMicellesRatsRats, Sprague-DawleyStaphylococcus aureusAnti-Bacterial AgentsAnti-Inflammatory AgentsBenzaldehydesMicellesPolyethylene Glycolspolyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymerPolyvinylsvanillin3D printingAlginateAntibacterial scaffoldFucoidanVanillinWound healing

Identifiers

PMID40890475
PMCPMC12402224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.